-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RjNmgX3gY5Tt/aEKgCzwe2hf9cSocUwUdxrPT1ROhPI+Z7C0cS9v+yh/fKptrYxn 7+T50W0munzEmTpnKocvTA== 0000947871-01-501084.txt : 20020411 0000947871-01-501084.hdr.sgml : 20020411 ACCESSION NUMBER: 0000947871-01-501084 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20011126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERRILL LYNCH PIERCE FENNER & SMITH INC CENTRAL INDEX KEY: 0000728612 STANDARD INDUSTRIAL CLASSIFICATION: ASSET-BACKED SECURITIES [6189] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-92161 FILM NUMBER: 1799202 BUSINESS ADDRESS: STREET 1: NORTH TOWER WORLD FINANCIAL CENTER STREET 2: NORTH TOWER WORLD FINANCIAL CENTER 5TH F CITY: NEW YORK STATE: NY ZIP: 10281-1323 BUSINESS PHONE: 2124496202 MAIL ADDRESS: STREET 1: WORLD FINANCIAL CENTER STREET 2: NORTH TOWER 23RD FL CITY: NEW YORK STATE: NY ZIP: 10281-1323 424B3 1 f424b3_112001.txt FORM 424B3 PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE NO. 424(b)(3) (To Prospectus dated January 23, 2001) REGISTRATION NO. 333-92161 333-95805 [PHARMACEUTICAL HOLDRS(SM) TRUST LOGO] 1,000,000,000 Depositary Receipts Pharmaceutical HOLDRS(SM) Trust This prospectus supplement supplements information contained in the prospectus dated January 23, 2001, which updated the original prospectus dated January 30, 2000 relating to the sale of up to 1,000,000,000 depositary receipts by the Pharmaceutical HOLDRS(SM) Trust. The share amounts specified in the table on page 11 of the base prospectus shall be replaced with the following: Share Primary Name of Company Ticker Amounts Trading Market - ------------------------------------ ------ ------- -------------- Abbott Laboratories ABT 14 NYSE Allergan, Inc. AGN 1 NYSE American Home Products Corporation AHP 12 NYSE Andrx Corporation-Andrx Group ADRX 2 Nasdaq NMS Biovail Corporation BVF 4 NYSE Bristol-Myers Squibb Company BMY 18 NYSE Eli Lilly & Company LLY 10 NYSE Forest Laboratories, Inc. FRX 2 NYSE ICN Pharmaceuticals, Inc. ICN 1 NYSE IVAX Corporation IVX 1.875 AMEX Johnson & Johnson JNJ 26 NYSE King Pharmaceuticals, Inc.(1) KG 4.25 NYSE Merck & Co., Inc. MRK 22 NYSE Mylan Laboratories, Inc. MYL 1 NYSE Pfizer Inc. PFE 58 NYSE Schering-Plough Corporation SGP 14 NYSE Watson Pharmaceuticals, Inc. WPI 1 NYSE Zimmer Holdings, Inc.(2) ZMH 1.8 NYSE --------------------------- (1) King Pharmaceuticals, Inc. announced a 4-for-3 stock split on its common stock payable to shareholders of record as of July 3, 2001. King Pharmaceuticals began trading on a split-adjusted basis on July 20, 2001. As of July 24, 2001, the share amount of King Pharmaceuticals, represented by a round-lot of 100 Pharmaceuticals HOLDRS, is 4.25. (2) On August 10, 2001, Bristol Myers Squibb Company completed its spin-off of Zimmer Holdings, Inc. As a result, Bristol Myers Squibb distributed 0.1 share of Zimmer Holdings common stock for each share of Bristol Myers Squibb. The share amount of Zimmer Holdings represented by a round lot of 100 Pharmaceutical HOLDRS is 0.3. The share amounts listed in the table above reflect all previous stock splits, dividends and business combination transactions. (continued on following page) ANNEX A ZIMMER HOLDINGS, INC. (ZMH) Zimmer Holdings, Inc. is engaged in the design, development, manufacturing and marketing of orthopedic reconstructive implants and fracture management products. Orthopedic reconstructive implants restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body's natural healing process. Zimmer Holdings also manufactures and markets other products relating to orthopedic and general surgery. Zimmer Holdings was spun-off from Bristol-Myers Squibb Company in August 2001.
Closing Closing Closing Closing Closing Closing 1996 Price 1997 Price 1998 Price 1999 Price 2000 Price 2001 Price January * January * January * January * January * January * February * February * February * February * February * February * March * March * March * March * March * March * April * April * April * April * April * April * May * May * May * May * May * May * June * June * June * June * June * June * July * July * July * July * July * July * August * August * August * August * August * August 27.20 September * September * September * September * September * September 27.75 October * October * October * October * October * November * November * November * November * November * December * December * December * December * December *
The date of this prospectus supplement is September 30, 2001. -----END PRIVACY-ENHANCED MESSAGE-----